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Abstract
The circadian oscillations of muscle genes are controlled either directly by the intrinsic muscle clock or by extrinsic
factors, such as feeding, hormonal signals, or neural influences, which are in turn regulated by the central
pacemaker, the suprachiasmatic nucleus of the hypothalamus. A unique feature of circadian rhythms in skeletal
muscle is motor neuron-dependent contractile activity, which can affect the oscillation of a number of muscle
genes independently of the muscle clock. The role of the intrinsic muscle clock has been investigated using
different Bmal1 knockout (KO) models. A comparative analysis of these models reveals that the dramatic muscle
wasting and premature aging caused by global conventional KO are not present in muscle-specific Bmal1 KO or in
global Bmal1 KO induced in the adult, therefore must reflect the loss of Bmal1 function during development in
non-muscle tissues. On the other hand, muscle-specific Bmal1 knockout causes impaired muscle glucose uptake
and metabolism, supporting a major role of the muscle clock in anticipating the sleep-to-wake transition, when
glucose becomes the predominant fuel for the skeletal muscle.
Keywords: Skeletal muscle, Circadian rhythms, Muscle clock, Bmal1 knockout, Muscle denervation, Glucose uptake,
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Background
All tissues of the body display circadian oscillations in
gene expression involving both the core clock genes,
which are common to all tissues, and a large number
of other genes, most of which are tissue-specific [1].
The core clock system consists of a transcriptional/
translational feedback loop whereby a complex of two
basic helix-loop-helix-PAS domain-containing tran-
scription factors, BMAL1 and CLOCK, induces the
expression of Per and Cry genes, whose products re-
press the transcription of Bmal1 and Clock, thus inhi-
biting their own transcription (Fig. 1a) [2]. Bmal1
expression is controlled by additional factors, RORs
and REV-ERBs, whose transcription is also regulated
by the BMAL1-CLOCK complex, and is further mod-
ulated by post-transcriptional changes, such as casein
kinase (CK)2-mediated phosphorylation [3]. Most core
clock genes show functional redundancy due to the
presence of variants, such as Per1 and Per2, or Cry1
and Cry2 genes, so that double knockouts are re-
quired to disrupt clock function; NPAS2 can substi-
tute for CLOCK as a partner for BMAL1, at least in
some tissues [2, 4]. In contrast, BMAL1 is a non-
redundant clock component, and its ablation has been
extensively used to determine the function of the
muscle clock. The circadian oscillations of most cellu-
lar genes are controlled either directly by the intrinsic
clock or by extrinsic factors, such as feeding, hormo-
nal signals, or neural influences, which are regulated
by the central pacemaker, the suprachiasmatic nucleus
(SCN) of the hypothalamus. Here, we briefly review
the regulation of circadian rhythms in the skeletal
muscle, focusing on the role of the intrinsic muscle
clock and critically considering the effects of different
Bmal1 knockout (KO) models. These studies reveal
that the intrinsic muscle clock is dispensable for
muscle growth and does not affect aging and life
span, in contrast to previous suggestions based on
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global Bmal1 KO. On the other hand, the muscle
clock has a crucial function in muscle metabolism, by
anticipating the changes in glucose uptake and oxida-
tion at the sleep-to-wake transition.
Extrinsic control of circadian rhythms in the
skeletal muscle: the role of motor activity
Peripheral oscillators, including the muscle clock, are
synchronized by the SCN through a variety of signals,
including daily variations in body temperature, humoral
factors, and the autonomic nervous system (reviewed in
[2]). Oscillations of tissue-specific circadian genes are
controlled either directly by the intrinsic peripheral
clocks or indirectly by extrinsic factors (Fig. 1b). For ex-
ample, inducible liver-specific repression of Bmal1 tran-
scription abrogates the oscillation of most circadian liver
genes, showing that they are directly controlled by the
hepatocyte clock; however, a number of other genes con-
tinue oscillating even in the absence of a functional liver
clock, showing that they are controlled by extrinsic fac-
tors [5]. Feeding has a dominant role in setting the
phase of peripheral oscillators, as temporal feeding re-
striction, induced by offering food only during the light
phase, radically changes the phase of both core clock
genes and other circadian genes in peripheral tissues of
mice [6], including the skeletal muscle [7]. Plasma gluco-
corticoid and body temperature rhythms are also in-
volved in the synchronization of peripheral clocks [2].
Another potential extrinsic circadian signal, which is
unique to skeletal muscle, is motor neuron-dependent
contractile activity.
Locomotor activity has traditionally been used both in
mice and in flies as a readout of the circadian timing
system. One may wonder whether motor neuron activity
regulates the intrinsic muscle clock and/or other muscle
cycling genes. Indeed, a phase distribution analysis of
the circadian muscle transcriptome revealed that the lar-
gest cluster of rhythmic genes is found at the midpoint
of the active phase [8]. Exercise was found to affect both
the amplitude and the phase of the circadian clock in
the skeletal muscle (reviewed in [9, 10]). However, inter-
pretation of these results is complicated by the fact that
exercise causes systemic effects, such as hormonal
changes and increased body temperature, which are
known to affect the peripheral oscillators. One-leg exer-
cise in humans allowed for direct comparisons between
active and inactive legs in the same individuals, thus ex-
cluding the potential contribution of systemic effects of
exercise: the expression of core clock genes and down-
stream targets was modified in the exercised but not in
the non-exercised contralateral leg; however, only two
time points were examined in this study [11].
An alternative approach to define the role of nerve ac-


















Fig. 1 Core clock mechanism and control of circadian muscle genes
by intrinsic and extrinsic pathways. a Simplified scheme of the core
clock mechanism. The clock consists of a stimulatory loop, with the
CLOCK-BMAL1 heterodimer stimulating the transcription of Per and Cry
genes, and an inhibitory feedback loop with the PER-CRY heterodimer
translocating to the nucleus and repressing the transcription of the
Clock and Bmal1 genes. An additional loop involves the ROR and
RevErb factors. The different isoforms of the clock genes, including the
genes coding for PER1 and PER2, CRY1 and CRY2, RORα and RORβ,
and RevErbα and RevErbβ, are not indicated in the scheme. b The
scheme illustrates how the master clock in the suprachiasmatic nuclei
(SCN) of the hypothalamus controls motor activity and other systemic
circadian rhythms (including feeding, hormone release, and body
temperature), which in turn modulate the circadian rhythm of the
muscle clock or directly dictate the oscillation of other muscle circadian
genes. Modified from [7]
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is to compare fast-twitch, sporadically active muscles,
composed by type 2 fibers, and slow-twitch, continu-
ously active muscles, composed by type 1 fibers. Total
daily activity, monitored by electromyography in rats,
differs by more than 50 times between motor units com-
posed of slow type 1 muscle fibers and motor units com-
posed of fast-type 2B fibers [12]. The circadian
expression pattern of the core clock genes was essen-
tially the same in the two types of muscles, although
most other circadian genes, including both clock-
dependent and clock-independent genes, were specific
for each muscle [7]. A more drastic experiment is to
compare completely inactive denervated muscles with
normally active contralateral muscles in the same ani-
mals. Core clock genes show small but significant
changes in phase, amplitude, and/or expression level in
the absence of motor nerve activity [7, 13]. For example,
the circadian phase of Bmal1 and its direct target, Dbp,
is advanced by about 3–4 h in denervated muscles, but
both amplitude and expression levels are unchanged
(Fig. 2). In addition, many other clock-dependent and
clock-independent muscle circadian genes show marked
alterations in absolute expression level, phase, and amp-
litude. Importantly, the circadian oscillation of plasma
glucocorticoids or the hepatic circadian expression of
clock genes are not altered by nerve section, suggesting
that systemic circadian rhythms are not affected in this
experimental system [13].
The calcineurin-NFAT signaling pathway is involved
in the nerve activity-dependent regulation of muscle
fiber-type-specific gene programs (reviewed in [14]),
and one member of the NFAT family, NFATc1, acts
as a slow-type nerve activity sensor in vivo [15, 16],
whereas other members of the NFAT family are also
responsive to fast-type nerve activity and might thus
contribute to modulate the fast fiber phenotype [17].
An NFATc1-GFP fusion protein, when electroporated
in skeletal muscles in vivo shows a predominantly
cytoplasmic localization in the fast tibialis anterior
muscle but a nuclear localization in the slow soleus.
A rapid nuclear translocation of NFATc1 can be in-
duced by electrical stimulation of tibialis anterior with
an impulse pattern typical of slow motor neurons,
while denervation causes a rapid nuclear export of
NFATc1 in soleus [16]. NFAT nuclear translocation
and transcriptional activity has been recently analyzed
during the day-night cycle [7]. NFATc1-GFP shows an
accumulation in mouse soleus myonuclei during the
dark phase with a peak at Zeitgeber (ZT)16, and a
similar circadian oscillation of luciferase activity is
seen after electroporation of an NFAT-luciferase con-
struct but with a 4–8-h delay. The NFAT target gene,
Rcan1.4, shows a similar circadian oscillation with a
peak during the dark phase, which is drastically
decreased in denervated muscle (Fig. 2). Interestingly,
Rcan1.4 circadian oscillation is unchanged in muscle-
specific Bmal1 mKO muscles, supporting the notion
that Rcan1.4 is a circadian muscle gene that is
dependent on activity but independent of the core os-
cillator. It is possible that some of the changes in-
duced by denervation may not reflect a direct effect
of the loss of nerve activity but might be due to the
transcriptional remodeling of gene expression that ac-
companies the denervation process. However, this


































Fig. 2 Changes in gene expression induced by muscle-specific
Bmal1 knockout (mKO), leading to disruption of the muscle clock, or
denervation (D), leading to loss of motor activity. Transcript levels
were monitored by qPCR every 4 h (0, lights on; 12, lights off). Three
representative genes are illustrated. Dbp, a direct target of Bmal1, is
strongly repressed by Bmal1 KO but shows only a phase advance of
around 4 h in denervated muscles without any change in oscillation
amplitude. In contrast, Rcan1.4, a gene controlled by motor neuron
activity via calcineurin-NFAT signaling, is essentially unchanged in
Bmal1 mKO muscles but is drastically downregulated by denervation.
Myod1, coding for the myogenic regulatory factor MyoD, shows an
atypical response, with circadian oscillation maintained with increased
amplitude in both Bmal1 mKO and denervated muscles. In denervation
experiments, the muscles were removed 7 days after sciatic nerve
section. The muscles examined were tibialis anterior for Dbp and
Myod1 and soleus for Rcan1.4 (data from [27]; changes in Myod1 are
unpublished observations)
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drastic reduction of Rcan1.4 gene expression during
the dark phase is already detected at 12 h after nerve
section, before any significant change in transcrip-
tional programs has taken place in denervated mus-
cles [7].
The role of the intrinsic muscle clock: lessons
from Bmal1 knockout models
The significance of the intrinsic muscle clock in muscle
physiology has been addressed using genetic loss-of-
function mouse models targeting the Bmal1 gene.
BMAL1 is a crucial component of the molecular clock,
and the only one for which loss results in complete dis-
ruption of circadian rhythms [18]. Different mouse lines
have been generated to inactivate the Bmal1 gene in the
skeletal muscles: as summarized in Table 1, these in-
clude both whole body and tissue-specific, constitutive,
and inducible KO models.
Mice with whole body Bmal1 KO, generated by
standard methods leading to deletion of the gene in
germinal cells, stop growing around 16 weeks of age,
display progressive and dramatic muscle atrophy and
decreased total activity level, and die between 26 and
52 weeks of age with signs of premature aging, in-
cluding arthropathy, decreased hair growth, ocular ab-
normalities such as cataracts, and neurodegeneration
with brain astrogliosis [18–20]. Bmal1 KO also causes
altered metabolism, including altered response to in-
sulin [21, 22] and ectopic fat accumulation in the
skeletal muscle [23]. Some of these changes could be
due to increased oxidative stress, since the loss of
Bmal1 is known to cause accumulation of reactive
oxygen species [19, 24] and antioxidant treatment was
found to ameliorate symptoms of premature aging
[25]. Muscle structure and function is altered in these
mice even at early stages of postnatal development: at
12–14 weeks of age, muscle force is decreased, ultra-
structural organization of thick and thin filament ap-
pears disrupted, and mitochondrial volume and
respiratory function are decreased [26]. It was sug-
gested that these changes are due to loss of function
of the muscle-specific regulatory factor MyoD, be-
cause similar changes were found in Myod1 null mice
and Myod1 was reported to be a target of BMAL1
and to lose its circadian oscillation in Bmal1 KO
mice [26]. However, this interpretation is in contrast
with a subsequent study on a muscle-specific Bmal1
KO model, obtained by crossing a mouse line bearing
a floxed Bmal1 with an Mlc1f-Cre line, bearing Cre
recombinase driven by the myosin light chain 1 fast
promoter [27]. These mice show drastic reduction of
Bmal1 transcripts in the skeletal muscle but not in
the heart and other organs; however, they have nor-
mal life span and body weight with no obvious sign
of premature aging. Muscle histology and ultrastruc-
ture are normal, and muscle weight is even increased
with a slight decrease in normalized muscle force
[27]. These findings suggest that the dramatic muscle
atrophy found in whole body Bmal1 KO mice cannot
result from a disrupted muscle clock or from loss of
cell-autonomous function of Bmal1 in muscle fibers
(see also [28]). In addition, Myod1 gene expression is
increased rather than decreased in these mice and
maintains its circadian oscillation with a peak during
the dark phase of the cycle (Fig. 2). A similar effect,
with an even greater upregulation of Myod1, is seen
after denervation. Based on these results, it seems un-
likely that MyoD can mediate the effect of BMAL1
function on the skeletal muscle, as previously sug-
gested [26]. On the other hand, Myod1 gene expres-
sion is apparently controlled by feeding, as Myod1
transcripts are strongly downregulated by fasting,
Table 1 Global phenotypes of different Bmal1 knockout models
Whole body Bmal1 KO Muscle-specific Bmal1 KO
Standard Standard + rescue with mBmal1a Inducible Standard Inducible
Circadian locomotor rhythm No No No Yes Yes Yes
Total activity level ↓ = = ↑ = =
Life span ↓ = = = = ND
Body weight ↓ = = = = ND
Muscle weight ↓ ND NDb ↑ = ND
Muscle fiber CSA ↓ ND ND ↑ = =
Muscle force (normalized) ↓ ND ND ↓ = ↓
Muscle fiber-type profile (fast muscles) ND ND ND ↓ 2X = ↓ 2B
References [18, 19, 26] [32] [30] [27] [27] [31, 55]
ND not determined, = unchanged, ↓ decreased, ↑ increased, CSA cross-sectional area
aMice with muscle-specific rescue of Bmal1 null mice, obtained by crossing Bmal1 global KO mice with Bmal1 transgenic mice bearing a Bmal1 DNA construct
driven by the muscle-specific α-actin promoter
bMuscle weight was not determined but was likely unchanged because body weight and the weight of most organs, including fat deposits, were unchanged
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under conditions when Bmal1 transcripts maintain
their normal levels and circadian pattern of expres-
sion [29].
Further insight into the function of Bmal1 in muscle fi-
bers was obtained by inducible Bmal1 KO models. A ubi-
quitously inducible KO model was generated by crossing a
floxed Bmal1 line with a tamoxifen-inducible universal
Cre line [30]. Tamoxifen treatment was started in 3-
month-old mice leading to Bmal1 inactivation in all tis-
sues at an adult stage, with the skeletal muscles showing a
99 % reduction of Bmal1 mRNA levels at Zeitgeber time 0
(ZT0, lights on), when Bmal1 expression is high. These
mice showed no significant difference in life span or body
and organ weight when compared to control, suggesting
that the dramatic phenotype seen in conventional Bmal1
KO mice results from BMAL1 function during develop-
ment. Hair growth is normal, and there is no sign of age-
dependent arthropathy or calcification, although brain
astrogliosis and ocular abnormalities, similar to those ob-
served with prenatal Bmal1 KO [20], were also evident
after postnatal Bmal1 depletion [30]. No difference was
seen in glucose tolerance test (GTT) and insulin tolerance
test (ITT) between KO and control mice. These results in-
dicate that most phenotypes in conventional Bmal1 KO
mice, previously attributed to disruption of circadian
rhythms, reflect the loss of properties of BMAL1 during
early development and are probably independent of its
role in the clock (see below). However, BMAL1 appears to
have a direct function in the eye and central nervous sys-
tem irrespective of developmental issues and probably due
to increased oxidative stress [30]. Muscle-specific indu-
cible models were generated by crossing a floxed Bmal1
line with a tamoxifen-inducible Cre driven by the human
α-actin promoter, thus inducing Bmal1 inactivation exclu-
sively in the skeletal muscle at an adult stage [27]. These
mice have an essentially normal phenotype with respect to
life span, body weight, and muscle mass (Table 1); how-
ever, they show altered glucose metabolism (see below).
Muscle force and the proportion of type 2B fibers were
decreased in these mice, whereas fiber size was unchanged
even at 12 months of age and centrally nucleated fibers
were not detected [31].
Taken together, these studies suggest that the dramatic
phenotype observed in the global Bmal1 KO, character-
ized by premature aging and death, with reduced body
weight and muscle wasting, reflects the loss of Bmal1
function during development in non-muscle tissues.
Two KO models support this conclusion. First, muscle-
specific Bmal1 KO, leading to Bmal1 deletion since early
developmental stages selectively in the skeletal muscle,
does not induce significant changes with the exception
of altered muscle metabolism [27], pointing to a major
effect of Bmal1 in non-muscle tissues in the pathogen-
esis of sarcopenia, premature aging, and reduced life
span. Second, these changes are also absent when Bmal1
KO is induced ubiquitously at an adult stage, therefore
must reflect the loss of Bmal1 during development [30].
However, another experimental model seems to contra-
dict this interpretation. Mice with muscle-specific rescue of
Bmal1 null mice, obtained by crossing Bmal1 global KO
mice with Bmal1 transgenic mice bearing a Bmal1 DNA
construct driven by the muscle-specific human α-actin pro-
moter, show normal body weight and total activity level, as
well as longer life span compared to Bmal1 null mice [32].
Although incomplete information was provided on some
critical aspects (life span profile, muscle weight), which
does not allow a thorough evaluation of this model, some
considerations could be put forward to explain this surpris-
ing result. A number of studies in Drosophila have revealed
that the skeletal muscle can affect the global body pheno-
type (reviewed in [33, 34]). This conclusion is supported by
studies in mammals, for example, reduced body size, but
essentially normal skeletal muscle phenotype, is observed
when myogenin, a muscle-specific transcription factor, is
deleted at birth using an inducible KO model [35]. Some ef-
fects of the skeletal muscle on the whole organism can be
mediated by the release of secreted factors from muscle
cells. Hundreds of muscle genes, potentially coding for se-
creted proteins, are expressed in skeletal muscle [36], and
specific myokines have been identified (reviewed in [37]).
Myokines can transmit signals from the muscles to adipose
tissue or other organs and, in this way, affect global aspects
of the phenotype (see [33, 34]). Interestingly, the secretion
of several myokines is strongly downregulated by siRNA
targeting Clock in skeletal myotubes, showing that the
muscle clock is involved in the regulation of basal myokine
secretion [38]. One wonders whether the muscle Bmal1-
dependent rescue of the phenotype of Bmal1 null mice is
mediated by a myokine release mechanism. Bmal1, like
other core clock genes, is expressed since early embryonic
stages in both the SCN and peripheral tissues but does not
oscillate during embryogenesis (Fig. 3), clock rhythm being
established during the first week after birth [39]. The role
of Bmal1 in the embryo is not known, but one possibility is
that this gene might have specific non-clock-related func-
tions, for which loss might account for premature aging
[30]. Indeed, a recent study indicates that BMAL1 stimu-
lates translation independently of its transcriptional activity.
The ribosomal S6 protein kinase 1 (S6K1), an important
mTOR-dependent regulator of translation, rhythmically
phosphorylates BMAL1, which in turn interacts with the
translational machinery, promoting protein synthesis [40].
Role of the muscle clock in glucose uptake and
metabolism
Glucose metabolism is altered by disruption of circadian
rhythms induced by SCN lesion or global inactivation of
clock genes (see [41]). However, both types of
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interventions profoundly affect behavior, including loco-
motor activity and feeding rhythms, and may thus indir-
ectly alter metabolism. Tissue-specific Bmal1 KO
models allow to identify the direct role of local clock
mechanisms in glucose metabolism in the presence of
normal locomotor activity and feeding rhythms. These
models have revealed the crucial contribution of periph-
eral clocks in the pancreas, liver, and skeletal muscle on
glucose metabolism (Fig. 4). Liver-specific ablation of
Bmal1 causes hypoglycemia during the fasting phase,
when plasma glucose is controlled by the liver through
glycogenolysis and gluconeogenesis, due to loss of rhyth-
mic expression of hepatic glucose regulatory genes, re-
sponsible for hepatic glucose production and export
[42]. Selective inactivation of Bmal1 in the pancreas or
in the β cells causes hyperglycemia due to impaired in-
sulin secretion [43–45], and isolated pancreatic islets
from adult mice display circadian oscillation in glucose-
stimulated insulin secretion which is abrogated by
Bmal1 ablation [46]. Transcriptome analyses showed
that a large number of genes involved in insulin secre-
tion display circadian changes in expression and
chromatin immunoprecipitation revealed that CLOCK
and BMAL1 control cycling genes in β cells by binding at
distal regulatory elements. Severe glucose intolerance is
induced in adult mice using a tamoxifen-inducible model
of pancreas-specific Bmal1 knockout [46]. On the other
hand, glucose metabolism in adipose tissue is apparently
unaffected by the local clock, as adipose tissue of mice
with adipocyte-specific KO of Bmal1 shows normal insu-
lin sensitivity compared to control littermates despite the
greater body adiposity [47].
The skeletal muscle is the predominant site of insulin-
stimulated glucose disposal in the postprandial state
[48], and muscle insulin resistance is one of the earliest
factors in the pathogenesis of the metabolic syndrome
[49, 50]. Dyar et al. [27], using both constitutive and in-
ducible muscle-specific Bmal1 KO models, revealed that
the muscle clock controls glucose uptake and metabol-
ism. This conclusion was based on studies of gene ex-
pression at the transcript and protein level, integrated by
enzymatic assays, glucose uptake studies, and circadian
metabolomics analyses. Insulin-stimulated glucose up-
take is impaired in the skeletal muscles from muscle-
specific Bmal1 KO mice, likely due to reduced transcript
and protein levels of glucose transporter 4 (GLUT4), the
insulin-dependent glucose transporter (Fig. 5). GLUT4
protein levels were reduced by 45 % across the diurnal
cycle, a change similar to that seen in heterozygous
GLUT4+/− mice, which also show a reduced insulin-
stimulated glucose uptake in the skeletal muscles [51].
Muscle-specific Bmal1 KO mice are also characterized
by reduced transcript and protein levels of TBC1D1, a
Rab-GTPase involved in GLUT4 translocation to the
plasma membrane. Tbc1d1 KO mice likewise show a





Fig. 3 Bmal1 and Per2 transcripts do not oscillate in embryonic
tissues. Twenty-four-hour expression profiles of Per2 and Bmal1
mRNA in embryonic (E18-E19) and adult mouse heart, as determined
by qPCR. Identical results were seen in the liver and kidney, while
the skeletal muscle was not analyzed in this study. Note that the
embryonic heart shows little circadian variation in Per2 and Bmal1
expression, in contrast with the robust changes seen in the adult







Fig. 4 The scheme illustrates the role of peripheral clocks in the control
of muscle glucose metabolism, as determined using tissue-specific Bmal1
knockout models. The liver clock controls glucose output during the
fasting/inactive phase, as shown by the finding that liver-specific Bmal1
KO causes hypoglycemia during this phase [42]. The pancreas β cell clock
controls insulin secretion, as β cell-specific Bmal1 KO causes hyperglycemia
[43–45]. The muscle clock promotes glucose uptake and metabolism at
awakening, as skeletal muscle-specific Bmal1 KO causes impaired
insulin-dependent glucose uptake and glucose oxidation in skeletal muscle
fibers [27]
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stimulated glucose uptake in the skeletal muscle [52];
therefore, it is likely that the loss of BMAL1 in the skel-
etal muscle causes decreased TBC1D1 levels which in
turn leads to reduced GLUT4 and impaired insulin-
stimulated glucose uptake. TBC1D1 has a circadian os-
cillation with a peak in the active/feeding phase but
starts to increase already in the late fasting phase. In con-
trast, the expression of another Rab-GTPase involved in
GLUT4 translocation, TBC1D4, shows no circadian oscilla-
tion in the skeletal muscle and is unaffected by Bmal1 KO
[27]. The phosphorylation of glucose to glucose-6-
phosphate by hexokinase is also affected by the muscle
clock, as suggested by the significantly reduced levels of
hexokinase 2 (HK2) after Bmal1 inactivation. Pyruvate de-
hydrogenase (PDH) activity is reduced in the skeletal mus-
cles due to altered expression of circadian genes Pdk4 and
Pdp1, coding for PDH kinase and phosphatase, respectively.
Under normal conditions, PDH kinase 4 (PDK4), which in-
hibits PDH activity, shows a peak of expression during the
fasting phase (around ZT4), whereas PDH phosphatase 1
(PDP1), which stimulates PDH activity, peaks around the
transition from the fasting to the feeding phase (around
ZT12). Interestingly, PDK4 starts to decrease whereas
PDP1 begins to increase during the fasting phase, before
awakening, supporting the notion of the anticipatory role
of the muscle clock, which prepares the muscles for the
upcoming activity period. Accordingly, muscle clock dis-
ruption leads to PDH inhibition, thus uncoupling glycoly-
sis from glucose oxidation, and contributing to the
diversion of glycolytic intermediates to alternative meta-
bolic pathways, as revealed by metabolomics analysis [27].
The tissue-specific role of BMAL1 in regulating insulin
sensitivity in muscle cells is supported by studies on cul-
tured C2C12 myotubes [53]. In these cells, insulin sensi-
tivity is reduced by knockdown of Clock or Bmal1, while
the insulin resistance induced by palmitate is improved by
Clock and Bmal1 overexpression [53]. These effects ap-
pear to be mediated by SIRT1, which is a target of
CLOCK and BMAL1, as shown by the finding that (i)
Sirt1 knockdown blocks the improvement induced by
Clock and Bmal1 overexpression on the palmitate-
dependent insulin resistance and (ii) Sirt1 overexpression















zeitgeber  time (hr)
Fig. 5 Simplified scheme of glucose uptake and metabolism in muscle cells, highlighting two crucial steps controlled by the intrinsic muscle
clock: insulin-dependent glucose uptake and pyruvate conversion to acetyl-CoA. Insulin promotes glucose uptake by activating the kinase AKT
that phosphorylates the Rab-GTPase-activating protein TBC1D1, thus promoting the translocation of GLUT4 to the plasma membrane. Pyruvate,
upon entry into mitochondria (mito), is metabolized to acetyl-CoA by pyruvate dehydrogenase (PDH), whose activity is inhibited by the PDH
kinase PDK4 and stimulated by the PDH phosphatase PDP1. The protein expression of GLUT4, and both mRNA and protein levels of TBC1D1,
PDK4, and PDP1 vary across the day-night cycle (0, lights on; 12, lights off) and are drastically affected by Bmal1 mKO. Under normal conditions,
PDK4 has a peak of expression in the fasting phase (around ZT4), whereas PDP1 peaks around the transition from the fasting to the feeding/active
phase (around ZT12). Note that PDK4 starts to decrease and PDP1 to increase during the fasting phase, before awakening, supporting the notion
of the anticipatory role of the muscle clock, which prepares the muscles to the upcoming activity period. These circadian adaptations are
completely disrupted by Bmal1 mKO, with downregulation of PDP1 and a rightward shift in the peak of PDK4, leading to decrease in PDH activity
at awakening (data from [27])
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Conclusions
The comparative analysis summarized in Table 1 shows
that the muscle phenotype is variably affected in differ-
ent Bmal1 KO models. In particular, the dramatic
muscle wasting and premature aging found in the global
conventional KO are not present in muscle-specific
Bmal1 KO or in global KO induced in the adult, thus
must reflect the loss of Bmal1 function during develop-
ment and in non-muscle tissues. These findings indicate
that the intrinsic muscle clock is dispensable for muscle
growth and that its inactivation does not cause prema-
ture aging and reduced life span. The fact that core
clock genes are not oscillating in embryonic tissues
points to possible non-clock functions of Bmal1 during
development, such as the recently identified BMAL1
role in the control of protein synthesis. On the other
hand, Bmal1 circadian oscillation in the skeletal muscle
is involved in adult muscle metabolism. In particular,
two models of muscle-specific inactivation of Bmal1
suggest that the intrinsic muscle clock controls both glu-
cose uptake and glucose metabolism in the skeletal
muscle and support the conclusion that “a major physio-
logical role of the muscle clock is to prepare the tissue
for the transition from the rest/fasting phase to the ac-
tive/feeding phase, when glucose becomes the predom-
inant fuel for skeletal muscle” [27]. It will be important
to confirm this conclusion with muscle-specific KO of
other clock genes, e.g., double KO of Per1 and Per2, or
Cry1 and Cry2, in order to establish unambiguously that
the changes in muscle metabolism induced by Bmal1
KO result from the disruption of the muscle clock and
not from specific functions of Bmal1.
Note added in proof
After submission of our manuscript we became aware of
a recent study describing another muscle-specific Bmal1
KO model obtained by crossing floxed Bmal1 with
MCK-Cre mice [54]. These mice have a normal life span,
thus confirming the results of Dyar et al. [27], and show
a denervation-induced increased in Myod1 expression
similar to that of wild type mice.
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